The contract covers the early-stage development and purification of the biological vaccine candidate.
Biovian_signs_a_deal_about_COVID_19_vaccine_development_and_manufacturing
Biovian signs an agreement about early-stage development and manufacturing of a COVID-19 vaccine candidate.
Biovian has signed an agreement with a European biopharmaceutical company for contract development and manufacturing of a COVID-19 vaccine.
Latest updates
3PBIOVIAN Contributes to Advancing Personalized Cancer Immunotherapies Through the PITÁGORAS Project
How to Prevail Over Common Bottlenecks in Recombinant Protein Development
The European CDMO Model, Powering Biologics Innovation
From Concept To Commercial Reality: Successful Upscaling Strategies For Viral Vector Manufacturing